CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $122,487
- in 1 filing, $122K under 10b5-1 plans
Net −$122,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Adams Kendra Chief Financial Officer | Sale 10b5-1 | −45,173 | $2.71 | $122K | 337,150 |
| 2026-09-18 | Adams Kendra Chief Financial Officer | Option exercise | +6,250 | 385,098 | ||
| 2026-09-18 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −2,775 | $3.39 | $9K | 382,323 |
| 2026-02-14 | Adams Kendra Chief Financial Officer | Option exercise | +30,950 | 400,479 | ||
| 2026-02-14 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −15,381 | $1.89 | $29K | 385,098 |
| 2026-02-13 | Adams Kendra Chief Financial Officer | Grant or award | +240,000 | 402,342 | ||
| 2026-02-13 | Adams Kendra Chief Financial Officer | Option exercise | +3,750 | 402,342 | ||
| 2026-02-13 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −1,863 | $1.89 | $4K | 400,479 |
| 2025-09-18 | Adams Kendra Chief Financial Officer | Option exercise | +6,250 | 165,117 | ||
| 2025-09-18 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −2,775 | $3.32 | $9K | 162,342 |
| 2025-02-14 | Adams Kendra Chief Financial Officer | Grant or award | +87,100 | 169,676 | ||
| 2025-02-14 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −4,559 | $3.18 | $14K | 165,117 |
| 2025-02-14 | Adams Kendra Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +130,600 | 130,600 | ||
| 2025-02-13 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −1,863 | $3.20 | $6K | 82,576 |
| 2024-11-07 | Adams Kendra Chief Financial Officer | Option exercise | +3,750 | 85,541 | ||
| 2024-11-07 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −1,102 | $6.04 | $7K | 84,439 |
| 2024-11-07 | Adams Kendra Chief Financial Officer | Option exercise · Performance Restricted Stock Units | −3,750 | 10,500 | ||
| 2024-09-18 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −1,837 | $6.38 | $12K | 81,791 |
| 2024-09-16 | Adams Kendra Chief Financial Officer | Option exercise | +2,250 | 84,289 | ||
| 2024-09-16 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −661 | $6.36 | $4K | 83,628 |
Page 1 of 2 · 28 trades